Arcus Biosciences, Inc Q2 Loss increases, but beats estimates

(RTTNews) - Arcus Biosciences, Inc (RCUS) reported Loss for its second quarter that increased from last year but beat the Street estimates.

The company's earnings totaled -$75 million, or -$1.04 per share. This compares with -$67 million, or -$0.93 per share, in last year's second quarter.

Analysts on average had expected the company to earn -$1.1 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 7.4% to $29 million from $27 million last year.

Arcus Biosciences, Inc earnings at a glance (GAAP) :

-Earnings (Q2): -$75 Mln. vs. -$67 Mln. last year. -EPS (Q2): -$1.04 vs. -$0.93 last year. -Analyst Estimate: -$1.1 -Revenue (Q2): $29 Mln vs. $27 Mln last year.